Retraction: Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver (Proceedings of the National Academy of Sciences of the United States of America (2013) 110 (12012-12017) DOI: 10.1073/pnas.1221733110);Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 29, 2013, Pages 12012-12017

  Zimmerman, Michael A ^a   Grenz, Almut ^b   Tak, Eunyoung ^b   Kaplan, Maria ^a   Ridyard, Douglas ^b   Brodsky, Kelley S ^b   Mandell, Mercedes Susan ^b   Kam, Igal ^a   Eltzschig, Holger K ^b  

^a Department of Surgery   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [6 AMINO 3,5 DICYANO 4 [4 (CYCLOPROPYLMETHOXY)PHENYL]PYRIDIN 2 YLSULFANYL]ACETAMIDE; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; BAY 60 6583; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER PROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELETION; HUMAN; HUMAN TISSUE; LIVER CELL; LIVER ISCHEMIA; LIVER PROTECTION; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VASCULAR ENDOTHELIUM; WILD TYPE;

EID: 84880389484     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1708494114     Document Type: Erratum

References (48)

1. Eltzschig HK, Sitkovsky M, Robson SC (2012) Purinergic signaling during inflammation. N Engl J Med 367(24):2322-2333.
2. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion-from mechanism to translation. Nat Med 17(11):1391-1401.
3. Cronstein BN, Daguma L, Nichols D, Hutchison AJ, Williams M (1990) The adenosine/neutrophil paradox resolved: Human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest 85(4): 1150-1157.
4. Rosenberger P, et al. (2009) Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 10(2):195-202.
5. Li L, et al. (2012) Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J Clin Invest 122(11):3931-3942.
6. Faigle M, Seessle J, Zug S, El Kasmi KC, Eltzschig HK (2008) ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS ONE 3(7):e2801.
7. Eltzschig HK, Macmanus CF, Colgan SP (2008) Neutrophils as sources of extracellular nucleotides: Functional consequences at the vascular interface. Trends Cardiovasc Med 18(3):103-107.
8. Synnestvedt K, et al. (2002) Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110(7):993-1002.
9. Hart ML, Gorzolla IC, Schittenhelm J, Robson SC, Eltzschig HK (2010) SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. J Immunol 184(7): 4017-4024.
10. Hart ML, et al. (2008) Extracellular adenosine production by ecto-5′-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology 135(5): 1739-1750.
11. Hart ML, et al. (2008) Use of a hanging-weight system for liver ischemic preconditioning in mice. Am J Physiol Gastrointest Liver Physiol 294(6):G1431-G1440.
12. Grenz A, et al. (2008) The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 5(6):e137.
13. Eckle T, et al. (2007) Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115(12):1581-1590.
14. Khoury J, Ibla JC, Neish AS, Colgan SP (2007) Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. J Clin Invest 117(3):703-711.
15. Liu W, et al. (2011) Sample preparation method for isolation of single-cell types from mouse liver for proteomic studies. Proteomics 11(17):3556-3564.
16. Grenz A, et al. (2012) Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 122(2):693-710.
17. Zhang X, Goncalves R, Mosser DM (2008) The isolation and characterization of murine macrophages. Curr Protoc Immunol Chapter 14:Unit 14.1.
18. Armstrong JM, et al. (2001) Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: Studies of cells from A2A-receptor-genedeficient mice. Biochem J 354(Pt 1):123-130.
19. Grenz A, Clambey E, Eltzschig HK (2012) Hypoxia signaling during intestinal ischemia and inflammation. Curr Opin Crit Care 18(2):178-185.
20. Hasko G, Csoka B, Nemeth ZH, Vizi ES, Pacher P (2009) A(2B) adenosine receptors in immunity and inflammation. Trends Immunol 30(6):263-270.
21. Németh ZH, et al. (2005) Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J Immunol 175(12):8260-8270.
22. Colgan SP, Taylor CT (2010) Hypoxia: An alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 7(5):281-287.
23. Waelchli R, et al. (2006) Design and preparation of 2-benzamido- pyrimidines as inhibitors of IKK. Bioorg Med Chem Lett 16(1):108-112.
24. Taylor CT (2008) Interdependent roles for hypoxia inducible factor and nuclear factorkappaB in hypoxic inflammation. J Physiol 586(Pt 17):4055-4059.
25. Taylor CT, Colgan SP (2007) Hypoxia and gastrointestinal disease. J Mol Med (Berl) 85(12):1295-1300.
26. Cummins EP, et al. (2006) Prolyl hydroxylase-1 negatively regulates IkappaB kinasebeta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci USA 103(48):18154-18159.
27. Eltzschig HK, et al. (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: Role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198(5):783-796.
28. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP (2006) HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 20(13):2242-2250.
29. Choukèr A, et al. (2012) In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor. Transplantation 94(9):894-902.
30. Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414(6866):916-920.
31. Thiel M, et al. (2005) Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol 3(6):e174.
32. Day YJ, et al. (2006) Renal ischemia-reperfusion injury and adenosine 2A receptormediated tissue protection: The role of CD4+ T cells and IFN-gamma. J Immunol 176(5):3108-3114.
33. Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J (2006) Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1ddependent NKT cell activation. J Exp Med 203(12):2639-2648.
34. Sitkovsky M, Lukashev D (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5(9):712-721.
35. Yilmaz G, Arumugam TV, Stokes KY, Granger DN (2006) Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113(17):2105-2112.
36. Thompson CA (2008) FDA approves pharmacologic stress agent. Am J Health Syst Pharm 65(10):890.
37. Field JJ, Nathan DG, Linden J (2011) Targeting iNKT cells for the treatment of sickle cell disease. Clin Immunol 140(2):177-183.
38. Schingnitz U, et al. (2010) Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol 184(9):5271-5279.
39. Hart ML, Jacobi B, Schittenhelm J, Henn M, Eltzschig HK (2009) Cutting edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol 182(7):3965-3968.
40. Eckle T, Koeppen M, Eltzschig HK (2009) Role of extracellular adenosine in acute lung injury. Physiology (Bethesda) 24(5):298-306.
41. Eltzschig HK (2009) Adenosine: An old drug newly discovered. Anesthesiology 111(4): 904-915.
42. Hart ML, et al. (2011) Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5′-nucleotidase (CD73) and the A2B adenosine receptor. J Immunol 186(7):4367-4374.
43. Hart ML, et al. (2008) Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 22(8):2784-2797.
44. Jackson EK, Ren J, Mi Z (2009) Extracellular 2′,3′-cAMP is a source of adenosine. J Biol Chem 284(48):33097-33106.
45. Jackson EK, Gillespie DG (2012) Extracellular 2',3′-cAMP-Adenosine pathway in proximal tubular, thick ascending limb and collecting duct epithelial cells. Am J Physiol Renal Physiol 304(1):F49-55.
46. Fredholm BB (2012) Rethinking the purinergic neuron-glia connection. Proc Natl Acad Sci USA 109(16):5913-5914.
47. Lovatt D, et al. (2012) Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc Natl Acad Sci USA 109(16): 6265-6270.
48. Decking UKM, Schlieper G, Kroll K, Schrader J (1997) Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ Res 81(2):154-164.